WHO guidelines on hepatitis B and C testing

Overview Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection ...

February 22, 2017
EATG  News  WHO Global  
Integrating ART postnatally improves outcomes for mothers, children
1600  

Integrating ART postnatally improves outcomes for mothers, children

SEATTLE — Integration of ART into maternal and child health services during the postnatal period leads to significant improvements in women’s participation in HIV care and resulting viral suppression, according to findings presented at the Conference on Retroviruses and Opportunistic Infections (CROI). “To understand the context ...

February 21, 2017
EATG  News  

Gaps identified in HIV care continuum research

Research on the continuum of HIV care must be improved and benchmarked against an integrated, comprehensive framework in order to make strides against the HIV epidemic, according to researchers at the Rollins School of Public Health, Johns Hopkins University, and the Centers for Disease Control ...

February 21, 2017
EATG  News  
BPaMZ and BPaL: Two new drug therapies might cure every form of TB
1519  

BPaMZ and BPaL: Two new drug therapies might cure every form of TB

Tuberculosis, the world’s leading infectious killer, may have finally met its match. Two new drug therapies may be able to cure all forms of tuberculosis – even the ones most difficult to treat. “We will have something to offer every single patient,” says Mel Spigelman, president ...

February 20, 2017
EATG  News  

HIV activist battles drugs and discrimination in Ukraine

Growing up in eastern Ukraine, Svitlana Moroz said she was a typically reckless teenager who believed she’d live forever. She shared needles with friends to inject opium, had unprotected sex with a guy her own age, and five months after hooking up with him, learned she ...

February 13, 2017
EATG  News  

Collaboration on novel cellular therapies for long term HIV control

Bioquark Inc. and SC21 Biotech are collaborating on novel cellular therapies for long term HIV control by cost effectively and industrially scaling the production of HIV resistant cells for allogeneic transplant needs. Phialdelphia, PA, February 11, 2017 – Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused ...

February 13, 2017
EATG  News  

Progress toward HIV cure highlighted

New Rochelle, NY, February 9, 2017—A comprehensive collection of articles describing the broad scope and current status of this global effort is published in a special issue of AIDS Research and Human Retroviruses, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The third annual ...

February 13, 2017
EATG  News  

WHO calls for list of essential diagnostics

Last June, a Perspective piece in the New England Journal of Medicine noted the critical place that the World Health Organization’s list of Essential Medicines had assumed in global health policy and responses — donors, governments and insurers were all more likely to invest in ...

February 13, 2017
EATG  News  

Africa-Europe partnership launched to develop new AIDS vaccine

A new partnership has been formed between European and African researchers to develop an AIDS vaccine that can be used to prevent infection with different strains of HIV worldwide. The Globally Relevant AIDS Vaccine Europe-Africa Trials Partnership (GREAT) will evaluate a new vaccine that triggers the ...

February 10, 2017
EATG  News  

High hepatitis C prevalence seen in Amsterdam PrEP study participants

Researchers from the Dutch pre-exposure prophylaxis (PrEP) demonstration study, AmPrEP, have found an unexpectedly high rate of hepatitis C virus (HCV) infection in participants tested for it at baseline. The HCV prevalence seen was more typical of that seen in HIV-positive gay men rather than the ...

February 07, 2017
EATG  News  

Hepatitis C genotype 4 combination therapy found to be safe and effective

Researchers recently published their findings on a combination therapy for use in patients with hepatitis C (HCV) genotype 4 in PLoS One. According to the Belgian researchers, sofosbuvir in combination with simeprevir with or without ribarivirn was found to be safe and effective. According to the ...

February 07, 2017
EATG  News  

Drug use and HIV: is there a correlation?

Although the use of needles to inject illegal drugs is a known risk factor in the transmission of HIV (more than 180,000 injectable drug users with HIV have died since the HIV epidemic began), less attention has been paid to general patterns of drug use ...

February 07, 2017
EATG  News